Antimicrobial peptides and the skin

Bibliography

• ZANETTI M, GENNARO R, ROMEO D: Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett. (1995) 374:1–5.
   PubMed Web of Science ®Google Scholar
• RITONJA A, KOPITAR M, JERALA R, TURK V: Primary structure of a new cysteine proteinase inhibitor from pig leucocytes. FEBS Lett. (1989) 255:211–214.
   PubMed Web of Science ®Google Scholar
• GENNARO R, SKERLAVAJ B, ROMEO D: Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils. Infect. Inman. (1989) 57:3142–3146.
   PubMed Web of Science ®Google Scholar
• AGERBERTH B, LEE JY, BERGMAN T et al.: Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur. j Biochem. (1991) 202:849–854.
   Google Scholar
• ZAIOU M, NIZET V, GALLO RL: Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL37) prosequence. 1 Invest. Dermatol (2003) 120:810–816.
   PubMed Web of Science ®Google Scholar
• AGERBERTH B, GUNNE H, ODEBERG J et al.: FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc. Natl. Acad. Sci. USA (1995) 92:195–199.
   PubMed Web of Science ®Google Scholar
• COWLAND JB, JOHNSEN AH, BORREGAARD N: hCAP-18, a cathelin/ probactenecin-like protein of human neutrophil specific granules. FEBS Lett. (1995) 368:173–176.
   PubMed Web of Science ®Google Scholar
• GUDMUNDSSON GH, AGERBERTH B, ODEBERG J, BERGMAN T, OLSSON B, SALCEDO R: The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur. Biochem. (1996) 238:325–332.
   PubMedGoogle Scholar
• SORENSEN OE, FOLLIN P, JOHNSEN AH et al.: Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood (2001) 97:3951–3959.
   PubMed Web of Science ®Google Scholar
• BALS R, WANG X, ZASLOFF M, WILSON JM: The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. USA (1998) 95:9541–9546.
   PubMed Web of Science ®Google Scholar
• AGERBERTH B, GRUNEWALD J, OLSSON E et al.: Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients. Am. Respir. Grit. Care Med. (1999) 160:283–290.
   PubMed Web of Science ®Google Scholar
• FROHM M, AGERBERTH B, AHANGARI G et al: The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. Biol. Chem. (1997) 272:15258–15263.
   Web of Science ®Google Scholar
• DORSCHNER RA, PESTONJAMASP VK, TAMAKUWALA S et al: Cutaneous injury induces the release of cathelicidin antimicrobial peptides active against group A Streptococcus. .1. Invest. Dermatol (2001) 117:91–97.
   PubMed Web of Science ®Google Scholar
• MALM J, SORENSEN O, PERSSON T et al.: The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentration, and is attached to spermatozoa. Infect. Immun. (2000) 68:4297–4302.
   PubMed Web of Science ®Google Scholar
• FROHM-NILSSON M, SANDSTEDT B, SORENSEN O, WEBER G, BORREGAARD N, STAHLE-BACKDAHL M: The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect. Immun. (1999) 67:2561–2566.
   PubMed Web of Science ®Google Scholar
• ISLAM D, BANDHOLTZ L, NILSSON J et al.: Downregulation of bacterial peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med. (2001) 7:180–185.
   PubMed Web of Science ®Google Scholar
• DE YANG, CHEN Q, SCHMIDT AP et al.: LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. .1. Exp. Med. (2000) 192:1069–1074.
   Google Scholar
• KOCZULLA R, VON DEGENFELD G, KUPATT C et al.: An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.j Clin. Invest. (2003) 111:1665–1672.
   Google Scholar
• NIYONSABA F, IWABUCHI K, SOMEYA A et al.: A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology (2002) 106:20–26.
   PubMed Web of Science ®Google Scholar
• DI NARDO A, VITIELLO A, GALLO RL: Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. I Immunol. (2003) 170:2274–2278.
   PubMed Web of Science ®Google Scholar
• GALLO RL, KIM KJ, BERNFIELD M et al.: Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J. Biol. Chem. (1997) 272:13088–13093.
   PubMed Web of Science ®Google Scholar
• NIZET V, OHTAKE T, LAUTH X et al.: Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature (2001) 414:454–457.
   PubMed Web of Science ®Google Scholar
• GALLO RL, ONO M, POVSIC T et al: Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc. Natl. Acad. Sci. USA (1994) 91:11035–11039.
   PubMed Web of Science ®Google Scholar
• RAJ PA, DENTINO AR: Current status of defensins and their role in innate and adaptive immunity. FEMS Microbiol. Lett. (2002) 206:9–18.
   PubMed Web of Science ®Google Scholar
• GANZ T, SELSTED ME, SZKLAREK D et al.: Defensins. Natural peptide antibiotics of human neutrophils. I Clin. Invest. (1985) 76:1427–1435.
   PubMed Web of Science ®Google Scholar
• LEHRER RI, DAHER K, GANZ T, SELSTED ME: Direct inactivation of viruses by MCP-1 and MCP-2, natural peptide antibiotics from rabbit leukocytes. Viral. (1985) 54:467–472.
   PubMed Web of Science ®Google Scholar
• HARWIG SS, GANZ T, LEHRER RI: Neutrophil defensins: purification, characterization, and antimicrobial testing. Methods. Enzymol. (1994) 236:160–172.
   PubMed Web of Science ®Google Scholar
• JONES DE, BEVINS CL: Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defence of the human bowel. FEBS Lett. (1993) 315:187–192.
   PubMed Web of Science ®Google Scholar
• SELSTED ME, MILLER SI, HENSCHEN AH, OUELLETTE AJ: Enteric defensins: antibiotic peptide components of intestinal host defence. Cell. Biol. (1992) 118:929–936.
   PubMed Web of Science ®Google Scholar
• QUAYLE AJ, PORTER EM, NUSSBAUM AA, WANG YM, BRABEC C, YIP KP et al: Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am. Pathol. (1998) 152:1247–1258.
   PubMed Web of Science ®Google Scholar
• OUELLETTE AJ, HSIEH MM, NOSEK MT et al.: Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms. Infect. Inman. (1994) 62:5040–5047.
   PubMed Web of Science ®Google Scholar
• CHALY YV, PALEOLOG EM, KOLESNIKOVA TS, TIKHONOV II, PETRATCHENKO EV, VOITENOK NN: Neutrophil alpha-defensin human neutrophil peptide modulates cytokine production in human monocytes and adhesion molecule expression in endothelial cells. Eur. Cytokine. Netw. (2000) 11:257–266.
   PubMed Web of Science ®Google Scholar
• DUITS LA, RAVENSBERGEN B, RADEMAKER M, HEIMSTRA PS, NIBBERING PH: Expression of 13-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunology (2002) 106:517–525.
   PubMed Web of Science ®Google Scholar
• FANG X-M, SHU Q, CHEN Q-X et al.:Differential expression of a- and 13-defensins in human peripheral blood. Ear: .1. Clin. Invest. (2003) 33:82–87.
   Google Scholar
• RYAN LK, DIAMOND G, AMRUTE S, FENG Z, WEINBERG A, FITZGERALD-BOCARSLY P: Detection of HBD1 peptide in peripheral blood mononuclear cell subpopulations by intracellular flow cytometry. Peptides (2004) (In Press).
   Google Scholar
• ZHAO C, WANG I, LEHRER RI: Widespread expression of human beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett. (1996) 396:319–322.
   PubMed Web of Science ®Google Scholar
• MCCRAY PB, BENTLEY L: Human airway epithelia express a beta-defensin. Am. I Respir. Cell Mol. Biol. (1997) 16:343–349.
   PubMed Web of Science ®Google Scholar
• VALORE EV, PARK CH, QUAYLE AJ, WILES KR, MC CRAY PB, GANZ T: Human I3-defensin-1: an antimicrobial peptide of urogenital tissues. J. Clin. Invest. (1998) 101:1633–1642.
   PubMed Web of Science ®Google Scholar
• HARDER J, BARTELS J, CHRISTOPHERS E, SCHRODER JM: A peptide antibiotic from human skin. Nature (1997) 387:861.
   PubMed Web of Science ®Google Scholar
• BALS R, WANG X, WU Z, FREEMAN T, BAFNA V, ZASLOFF M et al: Human I3-defensin 2 is a salt sensitive peptide antibiotic expressed in human lung. Clin. Invest. (1998) 102:874–880.
   Google Scholar
• HARDER J, BARTELS J, CHRISTOPHERS E, SCHRODER JM: Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. Biol. Chem. (2001) 276:5707–5713.
   Web of Science ®Google Scholar
• GARCIA JR, KRAUSE A, SCHULZ S et al.: Human I3-defensin 4: a novel human inducible peptide antibiotic with a specific salt-sensitive spectrum of antimicrobial activity. FASEB.I. (2001) 15:1819–1821.
   PubMed Web of Science ®Google Scholar
• SCHUTTE BC, MITROS JP, BARTLETT JA et al.: Discovery of five conserved beta-defensin gene clusters using a computational search strategy. Proc. Nati Acad. Si". USA (2002) 99:2129–2133.
   Google Scholar
• KAO CY, CHEN Y, ZHAO YH, REEN WU: ORFeome-based search of airway epithelial cell-specific novel human I3-defensin genes. Am. I Respir. Cell Mol. Biol. (2003) 29:71–80.
   PubMed Web of Science ®Google Scholar
• YANG D, CHERTOV O, BYKOVSKAIA SN et al: Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science (1999) 286:525–528.
   PubMed Web of Science ®Google Scholar
• BEFUS AD, MOWAT C, GILCHRIST M, HU J, SOLOMON S, BATEMAN A: Neutrophil defensins induce histamine secretion from mast cells: mechanisms of action. Iminunol (1999) 163:947–953.
   PubMed Web of Science ®Google Scholar
• LIU AY, DESTOUMIEUX D, WONG AV et al.: Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. Invest. Dermatol (2002) 118:275–281.
   PubMed Web of Science ®Google Scholar
• LIU L, ROBERTS AA, GANZ T: By IL-1 signaling, monocyte-derived cells dramatically enhance the epidermal antimicrobial response to lipopolysaccharide. Iminunol (2003) 170:575–580.
   PubMed Web of Science ®Google Scholar
• LIU L, WANG L, JIA HP et al: Structure and mapping of the human beta-defensin HBD-2 gene and its expression at sites of inflammation. Gene (1998) 222:237–244.
   PubMed Web of Science ®Google Scholar
• FULTON C, ANDERSON GM, ZASLOFF M, BULL R, QUINN AG: Expression of natural peptide antibiotics in human skin. Lancet (1997) 350:1750–1751.
   PubMed Web of Science ®Google Scholar
• SCHITTEK B, HIPFEL R, SAUER B et al.: Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat. Iminunol (2001) 2:1133–1137.
   PubMed Web of Science ®Google Scholar
• MURAKAMI M, OHTAKE T, DORSCHNER RA, SCHITTEK B, GARBE C, GALLO RL: Cathelieidin antimicrobial peptide expression in sweat, an innate defence system for skin. Invest. Del-mato] (2002) 119:1090–1095.
   PubMed Web of Science ®Google Scholar
• MARTINEZ A, ELSASSER TH, MURO-CACHO C et al: Expression of adrenomedullin and its receptor in normal and malignant human skin: a potential pluripotent role in the integument. Endocrinology (1997) 138:5597–5604.
   PubMed Web of Science ®Google Scholar
• ZEEUWEN PL, VAN VLIJMEN-WILLEMS IM, JANSEN BJ et al: Cystatin M/E expression is restricted to differentiated epidermal keratinocytes and sweat glands: a new skin-specific proteinase inhibitor that is a target for cross-linking by transglutaminase. Invest. Del-mato] (2001) 116:693–701.
   PubMed Web of Science ®Google Scholar
• ASHCROFT GS, LEI K, JIN W et al: Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat. Med. (2000) 6:1147–1153.
   PubMed Web of Science ®Google Scholar
• MALLBRIS L, O& BRIEN KP, HULTHEN A et al.: Neutrophil gelatinase-associated lipocalin is a marker for dysregulated keratinocyte differentiation in human skin. Exp. Del-mato] (2002) 11:584–591.
   Google Scholar
• ONG PY, OHTAKE T, BRANDT C et al.:Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl. J. Med. (2002) 347:1151–1160.
   PubMed Web of Science ®Google Scholar
• MARCHINI G, LINDOW S, BRISMAR H et al.: The newborn infant is protected by an innate antimicrobial barrier: peptide antibiotics are present in the skin and vernix caseosa. Br. Del-mato] (2002) 147:1127–1134.
   PubMed Web of Science ®Google Scholar
• CONNER K, NERN K, RUDISILL J et al.: The antimicrobial peptide LL-37 is expressed by keratinocytes in Condyloma acuminatum and Verruca vulgaris.J. Am. Acad. Dermatol (2002) 47:347–350.
   Google Scholar
• PHILPOTT MP: Defensins and acne. Immunol (2003) 40:457–462.
   Web of Science ®Google Scholar
• NOMURA I, GOLEVA E, HOWELL MD et al.: Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. Immunol (2003) 171:3262–3269.
   Web of Science ®Google Scholar
• HEILBORN JD, NILSSON ME KRATZ G et al.: The eathelieidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. Invest. Dermatol (2003) 120:379–389.
   Google Scholar
• SORENSEN OE, COWLAND JB, THEILGAARD-MONCH K, LIU L, GANZ T, BOREGAARD N: Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. Immunol (2003) 170:5583–5589.
   Web of Science ®Google Scholar
• ORTEGA MR, GANZ T, MILNER SM: Human beta defensin is absent in burn blister fluid. Burns (2000) 26:724–726.
   PubMed Web of Science ®Google Scholar
• DORSCHNER RA, LIN KH, MURAKAMI M, GALLO RL: Neonatal skin in mice and humans expresses increased levels of antimicrobial peptides: innate immunity during development of the adaptive response. Pediati: Res. (2003) 53:566–572.
   PubMed Web of Science ®Google Scholar
• YOSHIO H, TOLLIN M, GUDMUNDSSON GH et al: Antimicrobial polypeptides of the human vernix caseosa and amniotic fluid: implications for newborn innate defense. Pediatr. Res. (2003) 53:211–216.
   PubMed Web of Science ®Google Scholar
• FRICK IM, AKESSON P, RASMUSSEN M, SCHMIDTCHEN A, BJORCK L: SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides. Biol. Chem. (2003) 278:16561–16566.
   Web of Science ®Google Scholar
• SCHMIDTCHEN A, FRICK IM, ANDERSSON E, TAPPER H, BJORCK L: Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. MM. Microbiol (2002) 46:157–168.
   PubMed Web of Science ®Google Scholar